Published on the Packaging World Web site
| August 31, 1997
Type too small?
The Nonprescription Drug Manufacturers Assn. (NDMA) supports FDA's attempt to simplify OTC drug labels but called for greater flexibility in the proposed 6-point type size requirement.
NDMA estimates that over 30% of national OTC brand name products and 95% of store brand packages have small sizes or nontraditional shapes that aren't big enough to permit regulatory copy in 6-point type. Drug manufacturers NDMA said are doing their best to maximize type size without going below 4.5-point type.
© Copyright 2014 Summit Media Group, Inc. This copy is for your personal, noncommercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers click HERE
or use the "Reprints" tool that appears next to any article. Visit www.summitreprints.com
for samples and additional information. Order a reprint or license this article now.